{"transactions":[{"id":1643259,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-14T16:01:48.000Z","date":"2024-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Issuer restricted stock unit (\"Issuer RSU\") represents a contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) the Cash Amount, without interest and subject to any withholding of taxes; and (ii) one CVR for each Share subject to such Issuer RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) the Cash Amount, without interest and subject to any withholding of taxes; and (ii) one CVR for each Share subject to such Issuer RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) the Cash Amount, without interest and subject to any withholding of taxes; and (ii) one CVR for each Share subject to such Issuer RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001104659-24-023563","document":"tm246087-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465924023563/tm246087-4_4seq1.xml","form_type":"4"}},{"id":1643258,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T16:01:48.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of December 22, 2023, by and among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\") and Concentra Merger Sub II, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of February 14, 2024 (the \"Effective Time\") with the Issuer surviving the merger."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (a) $4.05 per Share in cash (the \"Cash Amount\"), subject to any applicable withholding taxes and without interest, plus (b) one non-transferable contractual contingent value right per Share (each, a \"CVR\"), which represents the right to receive potential payments, in cash, subject to any applicable tax withholding and without interest, all upon the terms and subject to the conditions as set forth in the Offer to Purchase, as amended, and in the related Letter of Transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-023563","document":"tm246087-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465924023563/tm246087-4_4seq1.xml","form_type":"4"}},{"id":1857293,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-13T17:29:34.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.001 per share, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date. The RSUs have no expiration date."}],"balance_after":3250,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001745020-23-000037","document":"wk-form4_1686691764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000174502023000037/wk-form4_1686691764.xml","form_type":"4"}},{"id":1857292,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T17:29:34.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date."}],"balance_after":19500,"derivative":{"exercise_price":9.61,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001745020-23-000037","document":"wk-form4_1686691764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000174502023000037/wk-form4_1686691764.xml","form_type":"4"}},{"id":2072730,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T07:05:31.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":9900,"price":4.9989,"value":49489.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001104659-23-000080","document":"tm2233814-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465923000080/tm2233814-1_4seq1.xml","form_type":"4"}},{"id":2072729,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T07:05:31.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":100,"price":5,"value":500.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001104659-23-000080","document":"tm2233814-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465923000080/tm2233814-1_4seq1.xml","form_type":"4"}},{"id":2265802,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-18T16:27:58.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied over a three-year period with 1/36th of the options vesting on June 17, 2022 and 1/36th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":8.02,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-018615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924322018615/doc4.xml","form_type":"4"}},{"id":3126633,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:34:12.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004066","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020004066/primarydocument.xml","form_type":"4"}},{"id":3276532,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T16:22:30.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter."}],"balance_after":129100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001562180-20-001108","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001108/primarydocument.xml","form_type":"4"}},{"id":3276531,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-12T16:22:30.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":24800,"price":50.11,"value":1242728.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001108","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001108/primarydocument.xml","form_type":"4"}},{"id":3276530,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-12T16:22:30.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":24800,"price":0.85,"value":21080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":24800,"source":{"system":"sec-edgar","filing":"0001562180-20-001108","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001108/primarydocument.xml","form_type":"4"}},{"id":3284253,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-07T16:19:16.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter."}],"balance_after":153900,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-20-001013","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001013/primarydocument.xml","form_type":"4"}},{"id":3284252,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T16:19:16.000Z","date":"2020-02-05","kind":"sale","acquired":false,"shares":2000,"price":50,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001013/primarydocument.xml","form_type":"4"}},{"id":3284251,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T16:19:16.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":2000,"price":0.85,"value":1700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001562180-20-001013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020001013/primarydocument.xml","form_type":"4"}},{"id":3306233,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-21T16:16:24.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter."}],"balance_after":155900,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001562180-20-000452","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000452/primarydocument.xml","form_type":"4"}},{"id":3306232,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T16:16:24.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":3200,"price":50.01,"value":160032.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-000452","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000452/primarydocument.xml","form_type":"4"}},{"id":3306231,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T16:16:24.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":3200,"price":0.85,"value":2720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3200,"source":{"system":"sec-edgar","filing":"0001562180-20-000452","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000452/primarydocument.xml","form_type":"4"}},{"id":3309265,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-16T16:18:59.000Z","date":"2020-01-14","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter."}],"balance_after":159100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-20-000391","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000391/primarydocument.xml","form_type":"4"}},{"id":3309264,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-16T16:18:59.000Z","date":"2020-01-14","kind":"sale","acquired":false,"shares":30000,"price":45.6,"value":1368000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $45.00 to $45.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-000391","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000391/primarydocument.xml","form_type":"4"}},{"id":3309263,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-16T16:18:59.000Z","date":"2020-01-14","kind":"exercise","acquired":true,"shares":30000,"price":0.85,"value":25500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-20-000391","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218020000391/primarydocument.xml","form_type":"4"}},{"id":3501922,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T16:21:05.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003293","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218019003293/primarydocument.xml","form_type":"4"}},{"id":3557843,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-11T20:06:02.000Z","date":"2019-04-09","kind":"exercise","acquired":false,"shares":6286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":3714,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":6286},"source":{"system":"sec-edgar","filing":"0001127430-19-000045","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000045/edgar.xml","form_type":"4"}},{"id":3557842,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-11T20:06:02.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":6286,"price":32.99,"value":207375.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":62197,"source":{"system":"sec-edgar","filing":"0001127430-19-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000045/edgar.xml","form_type":"4"}},{"id":3557841,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-11T20:06:02.000Z","date":"2019-04-09","kind":"exercise","acquired":true,"shares":6286,"price":3.03,"value":19046.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":68483,"source":{"system":"sec-edgar","filing":"0001127430-19-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000045/edgar.xml","form_type":"4"}},{"id":3629518,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-27T21:08:31.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total does not reflect previously reported transactions that occurred after February 15, 2019. This report has been filed late due to a broker reporting error."}],"balance_after":24900,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001127430-19-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000041/edgar.xml","form_type":"4"}},{"id":3629517,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T21:08:31.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":100,"price":27.9,"value":2790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":62197,"source":{"system":"sec-edgar","filing":"0001127430-19-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000041/edgar.xml","form_type":"4"}},{"id":3629516,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T21:08:31.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":100,"price":3.03,"value":303.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":62297,"source":{"system":"sec-edgar","filing":"0001127430-19-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000041/edgar.xml","form_type":"4"}},{"id":3632739,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-26T21:07:14.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":14900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":10100,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":14900},"source":{"system":"sec-edgar","filing":"0001127430-19-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000035/edgar.xml","form_type":"4"}},{"id":3632738,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-26T21:07:14.000Z","date":"2019-02-22","kind":"sale","acquired":false,"shares":14900,"price":28.08,"value":418392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":62197,"source":{"system":"sec-edgar","filing":"0001127430-19-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000035/edgar.xml","form_type":"4"}},{"id":3632737,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-26T21:07:14.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":14900,"price":3.03,"value":45147.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":77097,"source":{"system":"sec-edgar","filing":"0001127430-19-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000035/edgar.xml","form_type":"4"}},{"id":3898591,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-11T20:44:59.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":8912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2019."}],"balance_after":8912,"derivative":{"exercise_price":16.23,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":8912},"source":{"system":"sec-edgar","filing":"0001209191-18-036997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118036997/doc4.xml","form_type":"4"}},{"id":3898590,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T20:44:59.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":3081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units will vest one year after date of grant and vested shares will be payable in common stock. One (1) Restricted Stock Unit is the equivalent of one (1) share of Amicus Therapeutics, Inc. common Stock."}],"balance_after":8895,"source":{"system":"sec-edgar","filing":"0001209191-18-036997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118036997/doc4.xml","form_type":"4"}},{"id":3904830,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":14900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":189100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":14900},"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3904829,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":204000,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3904828,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":14900,"price":55.01,"value":819649.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $55.00 to $55.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3904827,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":14900,"price":0.85,"value":12665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":14900,"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3904826,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":100,"price":55,"value":5500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3904825,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T17:40:20.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":100,"price":0.85,"value":85.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001562180-18-002884","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002884/primarydocument.xml","form_type":"4"}},{"id":3913897,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T16:30:58.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 25, 2018."}],"balance_after":12500,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-002716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002716/primarydocument.xml","form_type":"4"}},{"id":3928750,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:14:49.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":6066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock."}],"balance_after":62197,"source":{"system":"sec-edgar","filing":"0001127430-18-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000040/edgar.xml","form_type":"4"}},{"id":3930482,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":9847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":204100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":9847},"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3930481,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-14","kind":"exercise","acquired":false,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":213947,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3930480,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":9847,"price":50.06,"value":492940.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3930479,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":9847,"price":0.85,"value":8369.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":9847,"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3930478,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":5153,"price":50.04,"value":257856.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3930477,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T16:15:33.000Z","date":"2018-05-14","kind":"exercise","acquired":true,"shares":5153,"price":0.85,"value":4380.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5153,"source":{"system":"sec-edgar","filing":"0001562180-18-002518","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002518/primarydocument.xml","form_type":"4"}},{"id":3936759,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-11T16:17:15.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":219100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-002456","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002456/primarydocument.xml","form_type":"4"}},{"id":3936758,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-11T16:17:15.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":15000,"price":45,"value":675000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002456","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002456/primarydocument.xml","form_type":"4"}},{"id":3936757,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-11T16:17:15.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":15000,"price":0.85,"value":12750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001562180-18-002456","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218018002456/primarydocument.xml","form_type":"4"}},{"id":4107766,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-01-04T22:08:29.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.53,"exercise_date":"2009-06-10","expiration_date":"2018-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-002047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002047/doc4.xml","form_type":"4"}},{"id":4107765,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-01-04T22:08:29.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017."}],"balance_after":0,"derivative":{"exercise_price":7.15,"exercise_date":"2010-06-10","expiration_date":"2019-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-002047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002047/doc4.xml","form_type":"4"}},{"id":4107764,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T22:08:29.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":20000,"price":15.0001,"value":300002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5814,"source":{"system":"sec-edgar","filing":"0001209191-18-002047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002047/doc4.xml","form_type":"4"}},{"id":4107763,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T22:08:29.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":20000,"price":15.0001,"value":300002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":25814,"source":{"system":"sec-edgar","filing":"0001209191-18-002047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002047/doc4.xml","form_type":"4"}},{"id":4160833,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-16T21:04:34.000Z","date":"2017-11-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127430-17-000085","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000085/edgar.xml","form_type":"4"}},{"id":4160832,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T21:04:34.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":15000,"price":32.5,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":56131,"source":{"system":"sec-edgar","filing":"0001127430-17-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000085/edgar.xml","form_type":"4"}},{"id":4160831,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T21:04:34.000Z","date":"2017-11-14","kind":"exercise","acquired":true,"shares":15000,"price":3.03,"value":45450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71131,"source":{"system":"sec-edgar","filing":"0001127430-17-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000085/edgar.xml","form_type":"4"}},{"id":4186498,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-13T16:16:23.000Z","date":"2017-10-11","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":234100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-003262","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003262/primarydocument.xml","form_type":"4"}},{"id":4186497,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-13T16:16:23.000Z","date":"2017-10-11","kind":"sale","acquired":false,"shares":20000,"price":34.95,"value":699000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-17-003262","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003262/primarydocument.xml","form_type":"4"}},{"id":4186496,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-13T16:16:23.000Z","date":"2017-10-11","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-17-003262","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003262/primarydocument.xml","form_type":"4"}},{"id":4199032,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-29T16:19:06.000Z","date":"2017-09-27","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":254100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-003045","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003045/primarydocument.xml","form_type":"4"}},{"id":4199031,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T16:19:06.000Z","date":"2017-09-27","kind":"sale","acquired":false,"shares":20000,"price":32.45,"value":649000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-17-003045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003045/primarydocument.xml","form_type":"4"}},{"id":4199030,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T16:19:06.000Z","date":"2017-09-27","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-17-003045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017003045/primarydocument.xml","form_type":"4"}},{"id":4205477,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-18","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":274100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4205476,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":294100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4205475,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-18","kind":"sale","acquired":false,"shares":20000,"price":29.95,"value":599000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4205474,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-18","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4205473,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-15","kind":"sale","acquired":false,"shares":20000,"price":27.45,"value":549000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4205472,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-19T16:20:37.000Z","date":"2017-09-15","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-17-002983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002983/primarydocument.xml","form_type":"4"}},{"id":4215004,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4215003,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4215002,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":70000,"derivative":{"exercise_price":3.03,"expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4215001,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":15000,"price":30,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":56131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4215000,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":15000,"price":3.03,"value":45450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4214999,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":15000,"price":29.5,"value":442500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":56131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4214998,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":15000,"price":3.03,"value":45450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4214997,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":15000,"price":29.5,"value":442500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":56131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4214996,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T20:46:58.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":15000,"price":3.03,"value":45450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71131,"source":{"system":"sec-edgar","filing":"0001127430-17-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000078/edgar.xml","form_type":"4"}},{"id":4214576,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-07T17:37:45.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":314100,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-002913","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002913/primarydocument.xml","form_type":"4"}},{"id":4214575,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T17:37:45.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":20000,"price":24.95,"value":499000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-17-002913","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002913/primarydocument.xml","form_type":"4"}},{"id":4214574,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T17:37:45.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001562180-17-002913","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000156218017002913/primarydocument.xml","form_type":"4"}},{"id":4281021,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-15T20:08:19.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":16236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2018."}],"balance_after":16236,"derivative":{"exercise_price":8.6,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":16236},"source":{"system":"sec-edgar","filing":"0001209191-17-040104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919117040104/doc4.xml","form_type":"4"}},{"id":4281020,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-15T20:08:19.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5814,"source":{"system":"sec-edgar","filing":"0001209191-17-040104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919117040104/doc4.xml","form_type":"4"}},{"id":4302719,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T17:01:09.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 24, 2017."}],"balance_after":12500,"derivative":{"exercise_price":18.85,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-014570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317014570/doc4.xml","form_type":"4"}},{"id":4312022,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-19T20:29:45.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6702,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock."}],"balance_after":56131,"source":{"system":"sec-edgar","filing":"0001127430-17-000043","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000043/edgar.xml","form_type":"4"}},{"id":4315374,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T17:00:41.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":8599,"price":19.04,"value":163724.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.65 to $19.275. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-013536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317013536/doc4.xml","form_type":"4"}},{"id":4326433,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T17:00:26.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":10000,"price":18.35,"value":183500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.10 to $18.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8599,"source":{"system":"sec-edgar","filing":"0000899243-17-012668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317012668/doc4.xml","form_type":"4"}},{"id":4334865,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-03T17:00:24.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares (\"Initial Shares\") and 116,831 of the shares subject to the option are contingent shares (\"Contingent Shares\"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares shall vest upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vest over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares vesting in 36 equal monthly installments thereafter."}],"balance_after":251382,"derivative":{"exercise_price":0.85,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-011652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317011652/doc4.xml","form_type":"4"}},{"id":4334864,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T17:00:24.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":25262,"price":22.43,"value":566626.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $22.00 to $22.925. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18599,"source":{"system":"sec-edgar","filing":"0000899243-17-011652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317011652/doc4.xml","form_type":"4"}},{"id":4334863,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T17:00:24.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":4738,"price":21.34,"value":101108.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.00 to $21.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43861,"source":{"system":"sec-edgar","filing":"0000899243-17-011652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317011652/doc4.xml","form_type":"4"}},{"id":4334862,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T17:00:24.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":20000,"price":0.85,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":48599,"source":{"system":"sec-edgar","filing":"0000899243-17-011652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317011652/doc4.xml","form_type":"4"}},{"id":4344465,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T21:00:35.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":10000,"price":20.98,"value":209800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.45 to $21.425. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28599,"source":{"system":"sec-edgar","filing":"0000899243-17-010932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202285/000089924317010932/doc4.xml","form_type":"4"}},{"id":4574960,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:33:16.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":11.38,"value":113800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting in four (4) equal quarterly installments following May 26, 2016, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":9.62,"expiration_date":"2026-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-16-151944","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151944/a4.xml","form_type":"4"}},{"id":4574959,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:33:16.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":8.57,"value":85700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which is fully vested was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":12.43,"expiration_date":"2025-05-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-16-151944","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151944/a4.xml","form_type":"4"}},{"id":4574958,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:33:16.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":17000,"price":13,"value":221000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in three equal annual installments following on September 24, 2014, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":8,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-16-151944","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151944/a4.xml","form_type":"4"}},{"id":4574957,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:33:16.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":18182,"price":15.71,"value":285639.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which is fully vested, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":5.29,"expiration_date":"2024-06-24","underlying":"Common Stock","underlying_shares":18182},"source":{"system":"sec-edgar","filing":"0001104659-16-151944","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151944/a4.xml","form_type":"4"}},{"id":644771,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, Americas"}}],"security":"Executive Option (right to buy)","published_at":"2005-03-03T22:33:52.000Z","date":"2005-03-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is not exercisable until the earlier of (i) the closing share price of common stock achieving a price of at least 15% above the option grant price and remaining at that price for seven consecutive trading days or (ii) the ninth anniversary of the grant date.  Shares underlying option vest 25% a year, on a cumulative basis, commencing one year after the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":25.45,"expiration_date":"2015-02-28","underlying":"Common Stock, $0.10 par value","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000014272-05-000070","document":"hay363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000070/hay363.xml","form_type":"4"}},{"id":644770,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, Americas"}}],"security":"Common Stock, $0.10 par value","published_at":"2005-03-03T22:33:52.000Z","date":"2005-03-01","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":207649,"source":{"system":"sec-edgar","filing":"0000014272-05-000070","document":"hay363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427205000070/hay363.xml","form_type":"4"}},{"id":650120,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, Americas"}}],"security":"Common Stock, $0.10 par value","published_at":"2004-12-03T21:00:09.000Z","date":"2004-12-01","kind":"tax_withholding","acquired":false,"shares":5174,"price":23.64,"value":122313.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock."}],"balance_after":190982,"source":{"system":"sec-edgar","filing":"0000014272-04-000192","document":"hay319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000192/hay319.xml","form_type":"4"}},{"id":659600,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, Americas"}}],"security":"Option (right to buy)","published_at":"2004-03-04T22:24:48.000Z","date":"2004-03-02","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant."}],"balance_after":110000,"derivative":{"exercise_price":28.11,"expiration_date":"2014-03-01","underlying":"Common Stock, $0.10 par value","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000014272-04-000071","document":"hay223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000071/hay223.xml","form_type":"4"}},{"id":659599,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":17557,"kind":"person","name":"HAYDEN DONALD J JR","position":1,"cik":"0001202285","reported_name":"HAYDEN DONALD J JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, Americas"}}],"security":"Common Stock, $0.10 par value","published_at":"2004-03-04T22:24:48.000Z","date":"2004-03-02","kind":"grant","acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":196156,"source":{"system":"sec-edgar","filing":"0000014272-04-000071","document":"hay223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427204000071/hay223.xml","form_type":"4"}}],"next_cursor":"2004-03-04T22:24:48.000000Z,659599"}